Title:
メンタアルベンシス抽出物を含む微塵による皮膚細胞損傷ケア用、皮膚バリア強化用、及び抗老化又は抗炎症組成物
Document Type and Number:
Japanese Patent JP7158426
Kind Code:
B2
Abstract:
The present specification relates to an external-use skin preparation composition containing a Mentha Arvensis extract as an active ingredient, and provides a composition for treating skin damage caused by fine dust, the composition regulating, to a normal level, the expression of any one or more selected from the group consisting of IL-1a(NM_000575), IL-1B(NM_000576), IL-36G(NM_019618), S100A7(NM_002963), LCE3D(NM_032563), PTGS2(NM_000963) and XDH(NM_000379), which are genes in skin cells and of which the expression is affected by fine dust. By using the composition for treating skin damage caused by fine dust, gene expression changed by fine dust can return to the normal level such that skin cell damage can be treated.
Inventors:
Kim Hyonjun
Kim, Mi Jin
Lee, Taeyoung
Kim, Mi Jin
Lee, Taeyoung
Application Number:
JP2019572193A
Publication Date:
October 21, 2022
Filing Date:
May 11, 2018
Export Citation:
Assignee:
AMOREPACIFIC CORPORATION
International Classes:
A61K36/534; A23L33/105; A61K8/9728; A61K8/9789; A61K35/74; A61P17/00; A61P17/16; A61P29/00; A61P39/02; A61P43/00; A61Q17/00; A61Q19/00; A61Q19/08; A61Q19/10
Domestic Patent References:
| JP2017513876A | ||||
| JP2012188399A | ||||
| JP2011148742A | ||||
| JP2008031111A | ||||
| JP2000212028A |
Foreign References:
| KR1020140052576A | ||||
| KR1020160109355A | ||||
| US20090155395 |
Other References:
Toxicology Letters,2017年03月21日,Vol. 273,pp. 26-35
Attorney, Agent or Firm:
Aiko Patent Office, a patent business corporation
Previous Patent: NK-1 ANTAGONIST COMPOSITIONS AND USE IN TREATMENT OF DEPRESSION
Next Patent: Globin gene therapy for treating hemoglobinopathies
Next Patent: Globin gene therapy for treating hemoglobinopathies